http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030060730-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6a0833d7d1f9d2a9cdb7e2bcb46f0e1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
filingDate 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243240135887396bc3fe7ea1c6434b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee4f20c37a6b7c0089a6403be3d4e786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e0274a838bbfa4481b55e45917f6d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb31ae8b342fe40040c894e362fbdbc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1474fa778dcd49c807e632ef27f41b6e
publicationDate 2003-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20030060730-A
titleOfInvention A sustained release pharmaceutical composition
abstract The present invention relates to a sustained release formulation composition for slowly releasing therapeutically active poorly soluble drugs, and more particularly, to a sustained release base composed of a poorly soluble drug, an acrylic polymer and a higher aliphatic alcohol, and a polyethylene glycol stimulating agent. And it relates to a sustained release formulation composition to maintain the effective blood concentration of the drug for a long time by the dissolution control excipient is a certain content ratio.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100540037-B1
priorityDate 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4795643-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5591452-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5763452-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4708874-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449757623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448517691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454016943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448882717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426382986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25147451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551899

Total number of triples: 52.